Heald,
J
(concurred
in
by
Jackett,
CJ
and
Ryan,
J)
(judgment
delivered
from
the
Bench):—This
is
an
appeal
from
a
judgment
of
the
Trial
Division
dismissing
an
appeal
from
the
Tax
Review
Board
which
in
turn
had
dismissed
the
appellant’s
appeal
from
an
assessment
dated
May
5,
1974,
increasing
for
the
purposes
of
Part
III
of
the
Income
Tax
Act
the
value
of
a
dividend
paid
by
the
appellant.
The
issue
in
this
appeal
is
whether
the
Trial
Division
should
have
changed
the
Minister’s
determination
of
the
value
expressed
in
money
of
a
dividend
of
shares
paid
by
appellant
on
August
7,
1969
to
its
parent
company
in
the
USA,
the
Bendix
Corporation
(hereinafter
Bendix).
Such
a
determination
is
necessary
for
the
purpose
of
calculating
the
15%
withholding
tax
payable
under
paragraph
106(1a)(a),
subsection
109(1)
and
paragraph
139(1)(a)
of
the
Income
Tax
Act,
RSC
1952,
c
148.
Those
sections
read
as
follows:
106.
(1a)
Every
non-resident
person
(a)
shall
pay
an
income
tax
of
15%
on
every
amount
that
a
person
resident
in
Canada,
other
than
a
person
described
in
paragraph
(b),
pays
or
credits,
or
is
deemed
by
Part
I
to
pay
or
credit
to
him
as,
on
account
or
in
lieu
of
payment
of,
or
in
satisfaction
of
a
dividend
other
than
(i)
a
dividend
from
a
non-resident-owned
investment
corporation
if
the
corporation
has,
previous
to
the
payment
of
the
dividend
and
at
a
time
when
it
was
taxable
under
section
70,
paid
dividends
(other
than
dividends
on
which
no
tax
was
payable
under
this
Part)
the
aggregate
amount
of
which
is
not
less
than
the
corporation’s
surplus
determined
in
prescribed
manner
for
taxation
years
for
which
it
was
not
taxable
under
section
70,
or
(ii)
a
dividend
that
would
not
be
included
in
computing
income
under
Part
I
by
virtue
of
section
67;
and
109.
(1)
When
a
person
pays
or
credits
or
is
deemed
to
have
paid
or
credited
an
amount
on
which
an
income
tax
is
payable
under
this
Part,
he
shall,
notwithstanding
any
agreement
or
any
law
to
the
contrary,
deduct
or
withhold
therefrom
the
amount
of
the
tax
and
forthwith
remit
that
amount
to
the
Receiver
General
of
Canada
on
behalf
of
the
non-resident
person
on
account
of
the
tax
and
shall
submit
therewith
a
statement
in
prescribed
form.
139.
(1)
In
this
Act,
(a)
“amount”
means
money,
rights
or
things
expressed
in
terms
of
the
amount
of
money
or
the
value
in
terms
of
money
of
the
right
or
thing;
The
appellant
is
a
wholly-owned
subsidiary
of
Bendix.
Bendix
is
a
corporation
resident
in
the
USA
and
not
resident
in
Canada.
The
appellant
was
the
registered
owner
of
517,313
shares
of
the
common
stock
of
Computing
Devices
of
Canada,
Limited
(hereinafter
CDC).
Such
shares
represented
66.75%
of
the
issued
and
outstanding
shares
of
CDC.
On
May
1,
1969
Bendix
entered
into
an
agreement
with
Control
Data
Corporation
(hereafter
Control
Data),
a
US
resident
corporation
with
which
it
dealt
at
arm’s
length,
pursuant
to
which
Bendix
agreed
to
exchange
its
shares
of
CDC
(which
were
beneficially
owned
by
Bendix
through
its
100%
shareholding
in
the
appellant)
on
the
basis
of
one
Control
Data
share
for
each
five
shares
of
CDC.
As
a
condition
to
the
Control
Data
exchange
offer,
Control
Data
required
that
the
Control
Data
shares
which
Bendix
was
to
receive
in
exchange
for
the
CDC
shares
be
subject
to
certain
restrictions.
Under
the
restrictions,
Bendix
was
obligated
not
to
sell
in
excess
of
25%
of
the
Control
Data
shares
within
the
first
year
after
acquiring
them
and
not
in
excess
of
50%
prior
to
two
years
from
the
date
of
acquisition.
A
formal
prospectus
and
take-over
bid
circular,
dated
May
15,
1969,
extended
the
offer
of
one
share
of
Control
Data
stock
for
each
five
shares
of
CDC
to
all
shareholders
of
CDC,
but
was
made
subject,
inter
alia,
to
Control
Data
acquiring
90%
of
the
outstanding
shares
of
CDC.
All
of
the
conditions
precedent
to
completion
of
the
exchange
offer
were
completed
by
July
31,
1969.
By
August
7,
1969,
97.9%
of
the
issued
and
outstanding
shares
of
CDC
had
been
tendered
pursuant
to
the
terms
of
the
exchange
offer.
On
August
7,
1969
Bendix
took
the
necessary
steps
to
fulfil
its
part
of
the
May
1,
1969
agreement
with
Control
Data.
This
involved:
(a)
convening
a
meeting
of
the
board
of
directors
of
the
appellant
(of
which
five
of
six
directors
were
employees
of
Bendix;
(b)
causing
it
to
declare
a
dividend
in
kind
of
the
CDC
shares;
and
(c)
immediately
tendering
the
CDC
shares
to
Control
Data.
The
restrictions
as
to
disposal
of
the
Control
Data
shares
had
the
effect
of
reducing
their
value
below
that
of
unrestricted
shares.
The
price
of
unrestricted
shares
of
Control
Data
on
August
7,
1969
was
US
$149.50.
One
expert
appraiser
testified,
at
the
trial,
that
an
average
value
for
the
shares
received
by
Bendix
as
of
August
7,
1969
would
be
US
$130
per
share.
No
contrary
evidence
was
given.
There
was
never,
at
any
time,
any
restriction
on
anyone
with
respect
to
the
sale
of
the
CDC
shares,
the
only
restriction
being
on
Bendix
with
respect
to
some
of
the
Control
Data
shares
which
it
received
in
exchange
for
CDC
shares.
The
appellant
itself
made
no
agreement
with
Control
Data
as
to
the
disposition
of
the
shares
of
CDC
which
it
was
declaring
and
paying
as
a
dividend
to
Bendix.
CDC
shares
traded
actively
on
the
Toronto
Stock
Exchange
between
January
1
and
August
31,
1969,
the
closing
prices
ranging
from
a
low
of
23
/s
on
February
28,
1969
to
a
high
of
34
on
August
20,
1969.
Sales
volume
of
the
CDC
shares
was
as
high
as
29,772
shares
on
January
24,.
1969
and
36,900
on
May
23,
1969,
but
the
last
day
on
which
there
was
a
substantial
volume
of
shares
traded
was
July
11,
1969,
when
3.825
shares
were
sold.
On
August
7,
1969,
the
day
the
dividend
in
question
was
declared,
50
shares
of
CDC
were
sold
at
$31
on
the
Toronto
Stock
Exchange.
Although
the
market
was
thin
after
July
11,
1969,
prices
for
CDC
shares
continued
to
rise
even
after
August
7,
1969
and,
with
a
few
exceptions,
were
above
$31
for
the
sales
made
during
the
balance
of
the
month
of
August
1969.
The
shares
of
CDC
were
not
evaluated
before
Bendix
commenced
nego
tiating
with
Control
Data
and
no
evidence
with
respect
to
the
value
of
the
CDC
shares
themselves,
other
than
the
market
value,
was
submitted
by
any
of
the
witnesses
at
trial.
Appellant’s
only
expert
witness
at
trial,
Mr
Haythe,
was
not
instructed
to
value
the
CDC
shares
that
comprised
the
dividend
and
he
expressed
no
opinion
as
to
their
value.
In
valuing
the
dividend
in
kind
of
the
CDC
shares
for
purposes
of
determining
the
“amount”
of
the
dividend
and
hence
the
tax
payable
under
section
106
of
the
Act,
the
appellant,
through
Bendix,
obtained
an
independent
valuation
of
the
Control
Data
shares
(for
which
the
CDC
shares
were
exchanged)
from
Mr
Madison
Haythe,
a
New
York
investment
banker.
The
Minister,
on
the
other
hand,
in
making
his
determination
of
the
amount
of
the
dividend,
multiplied
the
price
at
which
50
shares
of
CDC
traded
on
the
Toronto
Stock
Exchange
on
August
7,
1969
(ie,
Canadian
$31
per
share),
by
the
517,313
shares
of
CDC
comprising
the
dividend
in
kind.
The
sole
question
raised
by
this
appeal
is
the
“amount”
of
the
dividend
paid
by
the
appellant
to
its
parent
company.
As
the
dividend
consisted
of
a
block
of
shares
in
a
third
company,
that
“amount”
is
by
virtue
of
paragraph
139(1
)(a)
of
the
Income
Tax
Act,
the
“value”
in
terms
of
Canadian
money
of
that
block
of
shares.
In
my
view,
in
the
circumstances
of
this
case,
that
“value”
is
the
amount
for
which
they
would
have
been
sold
by
a
willing
well-informed
owner
of
such
shares
not
acting
under
pressure
to
a
willing
purchaser
not
acting
under
pressure.
In
applying
that
view,
it
must
be
borne
in
mind
that
the
block
of
shares
in
question
represents
a
majority
of
the
shares
in
a
relatively
closely
held
company
and
that
the
appellant
had
decided
that
it
no
longer
desired
to
have
the
responsibility
for
the
operation
of
the
business
carried
on
by
that
company.
As
I
appreciate
it,
there
were
two
main
branches
of
evidence
to
be
considered,
viz:
(a)
the
market
history
of
the
value
of
the
shares
that
were
held
by
persons
other
than
the
appellant
in
the
third
company;
and
(b)
the
consideration
received
for
the
block
of
shares
constituting
the
dividend
by
the
parent
company
from
a
purchaser
with
whom
it
was
dealing
at
arm’s
length
immediately
after
the
payment
of
the
dividend.
As
I
understand
the
facts,
either
the
learned
trial
judge
put
to
himself
the
wrong
question
or
he
was
clearly
wrong
in
concluding
that
the
evidence
of
the
market
value
of
the
minority
shares
(influenced
as
it
seems
to
have
been
by
the
exchange
offer
that
arose
out
of
the
negotiations
between
the
purchaser
and
the
parent
company)
outweighed
the
evidence
of
the
value
of
the
consideration
negotiated
with
an
arm’s
length
third
person
for
the
block
of
shares
constituting
the
dividend
at
the
relevant
time.
I
would
allow
the
appeal
with
costs
and
refer
the
matter
back
for
reassessment
on
the
basis
that
the
value
of
the
dividend
distributed
as
reported
by
the
appellant
should
not
have
been
increased.